Search

Author/Creator Figueroa-Parra, Gabriel

2. 626 The trajectory of Multimorbidity in patients with Systemic Lupus Erythematosus in the United States. (14th December 2022)

Authors:
Duarte-Garcia, Ali; Stevens, Maria; Heien, Herbert; Figueroa-Parra, Gabriel; Meade, Jose; Jeffery, Molly M; Thanarajasingam, Uma; Crowson, Cynthia; McCoy, Rozalina
Journal:
Lupus science & medicine
Issue:
Volume 9(2022)Supplement 3
Page Start:
A53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: 'Online management of rheumatoid arthritis during COVID-19 pandemic' by Zhang et al. Issue 1 (19th June 2020)

Authors:
Figueroa-Parra, Gabriel; Gamboa-Alonso, Carmen Magdalena; Galarza-Delgado, Dionicio Angel
Journal:
Annals of the rheumatic diseases
Issue:
Volume 80:Issue 1(2021)
Page Start:
e5
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Health Care Utilization in Systemic Lupus Erythematosus in the Community: The Lupus Midwest Network. Issue 1 (1st January 2023)

Authors:
Chevet, Baptiste; Figueroa-Parra, Gabriel; Valenzuela-Almada, Maria O.; Hocaoglu, Mehmet; Vallejo, Sebastian; Osei-Onomah, Shirley-Ann; Giblon, Rachel E.; Dabit, Jesse Y.; Chamberlain, Alanna M.; Cornec, Divi; Greenlund, Kurt J.; Barbour, Kamil E.; Crowson, Cynthia S.; Duarte-García, Alí
Journal:
Journal of clinical rheumatology
Issue:
Volume 29:Issue 1(2023)
Page Start:
29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Knowledge and attitudes about influenza vaccination in rheumatic diseases patients. Issue 5 (4th May 2021)

Authors:
Figueroa-Parra, Gabriel; Esquivel-Valerio, Jorge Antonio; Santoyo-Fexas, Leticia; Moreno-Salinas, Andrea; Gamboa-Alonso, Carmen Magdalena; De Leon-Ibarra, Ana Laura; Galarza-Delgado, Dionicio Angel
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 17:Issue 5(2021)
Page Start:
1420
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study. (November 2022)

Authors:
Figueroa-Parra, Gabriel; Gilbert, Emily L; Valenzuela-Almada, Maria O; Vallejo, Sebastian; Neville, Matthew R; Patel, Naomi J; Cook, Claire; Fu, Xiaoqing; Hagi, Ramla; McDermott, Gregory C; Dilorio, Michael A; Masto, Lucy; Vanni, Kathleen M M; Kowalski, Emily; Qian, Grace; Zhang, Yuqing; Wallace,...
Journal:
Lancet
Issue:
Volume 4:Number 11(2022)
Page Start:
e765
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APS. (24th March 2022)

Authors:
Liu, Hongjiang; Li, Chun; Shi, Hui; Guo, Yixue; Tang, Yundi; Chen, Chen; Zhao, Zhen; Hoy, Claire K; Yalavarthi, Srilakshmi; Figueroa-Parra, Gabriel; Duarte-Garcia, Ali; Zuo, Yu; Li, Zhanguo; Knight, Jason S; Guo, Jianping
Journal:
Rheumatology
Issue:
Volume 61:Number 12(2022)
Page Start:
4962
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al. Issue 1 (22nd June 2020)

Authors:
Gamboa-Alonso, Carmen Magdalena; Figueroa-Parra, Gabriel; Galarza-Delgado, Dionicio Angel
Journal:
Annals of the rheumatic diseases
Issue:
Volume 80:Issue 1(2021)
Page Start:
e7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗